• Eating whole grains helps cut diabetes risk
    New York, June 2 (IANS) Eating higher intake of high-quality carbohydrates, especially from whole grains, are associated with a lower risk for type 2 diabetes, say researchers.   "High intake of carbohydrates has been suggested to be associated with a higher risk of type 2 diabetes," said study lead author Kim Braun from Harvard University in the US.   For the findings, the research team looked at whether this effect is different for high-quality carbohy
  • Covid-19 could be seasonal illness with higher risk in winter: Study
    Image for representational purpose only   Sydney, June 2 (IANS) Covid-19 could be a seasonal illness with a higher risk in winter as researchers have found a one per cent decrease in humidity could increase the number of Covid-19 cases by six per cent.   The study, published in the journal Transboundary and Emerging Diseases, has found an association between lower humidity and an increase in locally acquired positive cases.   "Covid-19 is likely to
  • Choline helps lower effects of Covid-19 on newborns: Study
    New York, June 2 (IANS) Pregnant women who take extra choline supplements may be able to mitigate the negative impact viral respiratory infections, including Covid-19, may have on their babies, say researchers.   Choline is a vitamin B nutrient found in various foods and dietary supplements and is critical to fetal brain development.   "The Centers for Disease Control and Prevention (CDC) predicts that Covid-19 will impact fetal brain development like other c
  • Roche gets green signal for COVID antibody test
    New Delhi, June 1 (IANS) Roche Diagnostics India on Monday said it welcomed Indian Council of Medical Research's communication regarding its COVID-19 antibody test for seroprevalence studies in India.   Dr Shravan Subramanyam, Managing Director, Roche Diagnostics India said, "Roche Diagnostics India welcomes ICMR's communication that cites making available Roche COVID-19 antibody test for seroprevalence studies in India."   According to Subramany
  • Russia to roll out its first approved Covid-19 drug next week
    Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the head of Russia’s RDIF sovereign wealth fund told Reuters in an interview   Moscow, June 1 (Reuters): Russia will start giving its first drug approved to treat Covid-19 to patients next week, its state financial backer told Reuters, a move it hopes will ease strains on the health system and speed a return to normal economic life.   R
  • Dairy intake may not prevent age-related bone loss in women: Study
    New York, June 1 (IANS) Researchers have found that despite containing essential nutrients, dairy products do not benefit lumbar spine or femoral neck bone density, nor do they protect against fracture risk in women.   The study, based on data from the Study of Women's Health Across the Nation (SWAN) shows that during the menopause transition, when bone loss is accelerated, they offer little benefit in preventing bone mineral density loss or fractures.   Accor
  • COVID-19 patients who undergo surgery at high death risk: Lancet
    London, May 31 (IANS) Researchers, including one of Indian-origin, have found that patients undergoing surgery after contracting COVID-19 are at greatly increased risk of postoperative death, according to a new global study published in The Lancet journal.   Published in 'The Lancet' journal, the global study found that amongst SARS-CoV-2 infected patients who underwent surgery, mortality rates approach those of the sickest patients admitted to intensive care after c
  • New method to help epidemiologists map COVID-19 spread
    New York, May 31 (IANS) Researchers have developed a method they believe will help epidemiologists predict more efficiently the spread of the COVID-19 pandemic.   The study, published in the journal Physica D: Nonlinear Phenomena, outlines a solution to the 'SIR' epidemic model, which is commonly used to predict how many people are susceptible to, infected by, and recovered from viral epidemics.   The method has been created by researchers from the Rochest
  • 'Covid-19 vac likely in 2020, but production only by 2021-end'
    New Delhi, May 30 (IANS) Sweden's chief epidemiologist Dr Anders Tegnell said Covid-19 vaccine may be developed in 2020, but its production will only start by the end of 2021.   In a webinar organized by Public Health Foundation of India, Tegnell, who is also the architect of Covid-19 Sweden's lockdown-lite, said: "To reach full herd immunity to stop the disease and may be get rid of the disease in the long term, by certain you need a vaccine.   "
  • Covid-19 vaccine could be ready by October, claims Pfizer CEO
    New York, May 30 (IANS) Global pharmaceutical major Pfizer believes that a vaccine to prevent Covid-19 could be ready by the end of October, the company's CEO Albert Bourla said.   Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech.   Bourla made the comments while participating at a virtual event organised by the International Federation of Pharmaceu
  • Timely heart surgery saves woman's life amid corona lockdown
    New Delhi, May 29 (IANS) Even as non-COVID patients were facing problems in getting treatment amid the novel coronavirus outbreak, a very high-risk open-heart surgery at a hospital in Delhi helped save a 31-year-old woman's life during the ongoing nationwide lockdown.   Kirti of Rohini was suffering from chronic cardiac ailments for the past four years, though her condition deteriorated severely in the last week of April amid the lockdown. She required an urgent open-hea
  • Early exposure to anaesthetics may trigger alcohol use disorder
    New York, May 28 (IANS) Early exposure to anaesthetics in life may make adolescents more susceptible to developing alcohol use disorder (AUD), warn researchers.   Anaesthetics are commonly used drugs in the healthcare field and are often administered to children to induce unconsciousness and immobility during surgeries.   For the findings, published in the journal Alcoholism: Clinical & Experimental Research, the research team examined whether exposure to anes
  • Prevalence of 'silent' Covid-19 infections much higher than thought
    Sydney, May 28 (IANS) The prevalence of 'silent' symptomless COVID-19 infections may be much higher than thought and as countries progress out of lockdown, a high proportion of asymptomatic individuals may mean a much higher percentage has been infected with the coronavirus, according to a study of people isolated on a cruise ship during the pandemic.   Published in the journal Thorax, the study from Australian researchers revealed that more than eight out of 10 of p
  • Smoking and how it affects fertility, childbirth
    New Delhi, May 28 (IANSlife) Smoking and tobacco use can have a serious impact on the fertility of both men and women, and consequently the quality of life in pregnancy.   If a woman is a regular smoker, then it has a double effect on a woman's fertility. Smoking can harm both the eggs and the uterus. It not only affects her egg quality, but can also have endometrial effect. Many studies too have shown that smoking can have negative effects on fertility, notes Dr Apurva
  • India's HCQ pioneer slams WHO decision to suspend drug trial
    New Delhi, May 27 (IANS) One of the pioneers to initiate hydroxychloroquine (HCQ) therapy in COVID-19 positive patients, Dr Sudhir Bhandari , Principal and Controller, Sawai Madho Singh Medical College Hospitals, Jaipur has slammed the decision of the World Health Organisation (WHO) to temporarily put on hold the HCQ trial.   Sharing his views with IANS, Bhandari said the WHO decision has drawn severe censure and flak from the medical fraternity across India.   Th
  • COVID-19 here to stay till 2021, aggressive testing needed to curb its spread: Health experts
    New Delhi, May 27 (PTI) Global health experts on Wednesday said novel coronavirus is here to stay for more than a year and called for aggressive testing to prevent its spread.   In an interaction with Congress leader Rahul Gandhi, health experts Professor Ashish Jha and Professor Johan Giesecke talked about the COVID-19 pandemic as part of the series being aired on Congress social media channels.   While Jha exuded confidence that a vaccine will be available in a
  • Spirituality linked to higher quality of life for stroke survivors
    London, May 26 (IANS) Higher spirituality among stroke survivors was strongly linked to a better quality of life for them and their caregivers who may also feel depressed, say researchers.   For many stroke survivors, a caregiver, often a family member or a close friend, may help with the daily tasks, making the survivor and the caregiver prone to depression. Depression can impact the quality of life for both.   "Research shows that spirituality may help some
  • India to continue using HCQ as prophylaxis for COVID: ICMR
    New Delhi, May 26 (IANS) The Indian Council of Medical Research on Tuesday said it will continue using hydroxychloroquine (HCQ) medicine as prophylaxis for COVID-19 disease.   Speaking at a press conference, Dr Balram Bhargava, Director General (DG) of the ICMR, told the media that the Council found the drug very effective and having less side effects for prophylaxis consumption.   The clinical trial of the HCQ on COVID-19 patients was suspended by the World Healt
  • Fujifilm research into COVID-19 drug spills into June, dashing hope of May approval
    TOKYO, May 26 (Reuters) - Research into Fujifilm Holdings Corp’s (4901.T) Avigan will continue into June, Japan’s government said on Tuesday, effectively dashing hopes by Prime Minister Shinzo Abe that the drug would be approved as a COVID-19 treatment this month.   Abe had said he hoped the drug would be approved in May if its efficacy and safety could be confirmed.   “The company will continue research into next month or so, and if an applicati
  • Young adults more likely to die from epilepsy: Study
    London, May 25 (IANS) A new study has claimed that young adults aged between 16 and 24 may have a six-fold increased risk of epilepsy-related death, a disorder in which nerve cell activity in the brain is disturbed, causing seizures.   The study, presented at the European Academy of Neurology (EAN) Virtual Congress, found that mortality rates for epilepsy-related deaths did not decrease between 2009 (6.8 per 100,000) and 2015 (9.1 per 100,000), despite advances in treatment